Franco, Fabien
Jaccard, Alison http://orcid.org/0000-0002-7737-3118
Romero, Pedro http://orcid.org/0000-0002-9688-2882
Yu, Yi-Ru http://orcid.org/0000-0002-3562-3502
Ho, Ping-Chih http://orcid.org/0000-0003-3078-3774
Funding for this research was provided by:
Cancer Research Institute
Article History
Received: 30 November 2019
Accepted: 12 August 2020
First Online: 21 September 2020
Competing interests
: P.-C.H. is serving as a scientific advisory board member for Elixiron Immunotherapeutics and Acepodia. P.-C.H. receives research grants from Roche and has received honoraria from Pfizer and Chugai. P.R. also receives research grants from Roche. The other authors have no conflict of interest.